295 related articles for article (PubMed ID: 34437655)
1. Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression.
Morelli KA; Kerkaert JD; Cramer RA
PLoS Pathog; 2021 Aug; 17(8):e1009794. PubMed ID: 34437655
[TBL] [Abstract][Full Text] [Related]
2. Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance.
Kowalski CH; Morelli KA; Schultz D; Nadell CD; Cramer RA
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22473-22483. PubMed ID: 32848055
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.
Perdoni F; Signorelli P; Cirasola D; Caretti A; Galimberti V; Biggiogera M; Gasco P; Musicanti C; Morace G; Borghi E
BMC Microbiol; 2015 Oct; 15():248. PubMed ID: 26519193
[TBL] [Abstract][Full Text] [Related]
4. Biofilm formation by Aspergillus fumigatus.
Kaur S; Singh S
Med Mycol; 2014 Jan; 52(1):2-9. PubMed ID: 23962172
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus fumigatus biofilms in the clinical setting.
Müller FM; Seidler M; Beauvais A
Med Mycol; 2011 Apr; 49 Suppl 1():S96-S100. PubMed ID: 21254964
[TBL] [Abstract][Full Text] [Related]
6. An Alanine Aminotransferase Is Required for Biofilm-Specific Resistance of Aspergillus fumigatus to Echinocandin Treatment.
Kerkaert JD; Le Mauff F; Wucher BR; Beattie SR; Vesely EM; Sheppard DC; Nadell CD; Cramer RA
mBio; 2022 Apr; 13(2):e0293321. PubMed ID: 35254131
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?
Mowat E; Williams C; Jones B; McChlery S; Ramage G
Med Mycol; 2009; 47 Suppl 1():S120-6. PubMed ID: 18654926
[TBL] [Abstract][Full Text] [Related]
8. Filamentous fungal biofilms: Conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus.
Liu S; Le Mauff F; Sheppard DC; Zhang S
NPJ Biofilms Microbiomes; 2022 Oct; 8(1):83. PubMed ID: 36261442
[TBL] [Abstract][Full Text] [Related]
9. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Seidler MJ; Salvenmoser S; Müller FM
Antimicrob Agents Chemother; 2008 Nov; 52(11):4130-6. PubMed ID: 18710910
[TBL] [Abstract][Full Text] [Related]
10. Analysis and description of the stages of Aspergillus fumigatus biofilm formation using scanning electron microscopy.
González-Ramírez AI; Ramírez-Granillo A; Medina-Canales MG; Rodríguez-Tovar AV; Martínez-Rivera MA
BMC Microbiol; 2016 Oct; 16(1):243. PubMed ID: 27756222
[TBL] [Abstract][Full Text] [Related]
11. In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.
Bugli F; Posteraro B; Papi M; Torelli R; Maiorana A; Paroni Sterbini F; Posteraro P; Sanguinetti M; De Spirito M
Antimicrob Agents Chemother; 2013 Mar; 57(3):1275-82. PubMed ID: 23263007
[TBL] [Abstract][Full Text] [Related]
12. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus.
Mowat E; Butcher J; Lang S; Williams C; Ramage G
J Med Microbiol; 2007 Sep; 56(Pt 9):1205-1212. PubMed ID: 17761484
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases in the Prevention of Experimental Invasive Aspergillosis.
Ostapska H; Raju D; Lehoux M; Lacdao I; Gilbert S; Sivarajah P; Bamford NC; Baker P; Nguyen TTM; Zacharias CA; Gravelat FN; Howell PL; Sheppard DC
mBio; 2021 Oct; 12(5):e0244621. PubMed ID: 34579578
[TBL] [Abstract][Full Text] [Related]
14. Effect of serum components on biofilm formation by Aspergillus fumigatus and other Aspergillus species.
Wuren T; Toyotome T; Yamaguchi M; Takahashi-Nakaguchi A; Muraosa Y; Yahiro M; Wang DN; Watanabe A; Taguchi H; Kamei K
Jpn J Infect Dis; 2014; 67(3):172-9. PubMed ID: 24858605
[TBL] [Abstract][Full Text] [Related]
15. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms.
Rajendran R; Williams C; Lappin DF; Millington O; Martins M; Ramage G
Eukaryot Cell; 2013 Mar; 12(3):420-9. PubMed ID: 23314962
[TBL] [Abstract][Full Text] [Related]
16. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.
Dos Reis TF; Horta MAC; Colabardini AC; Fernandes CM; Silva LP; Bastos RW; Fonseca MVL; Wang F; Martins C; Rodrigues ML; Silva Pereira C; Del Poeta M; Wong KH; Goldman GH
mBio; 2021 Aug; 12(4):e0145821. PubMed ID: 34372704
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
Lamoth F; Juvvadi PR; Steinbach WJ
Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus Biofilm In Vitro and In Vivo.
Beauvais A; Latgé JP
Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350307
[TBL] [Abstract][Full Text] [Related]
19. cspA influences biofilm formation and drug resistance in pathogenic fungus Aspergillus fumigatus.
Fan Z; Li Z; Xu Z; Li H; Li L; Ning C; Ma L; Xie X; Wang G; Yu H
Biomed Res Int; 2015; 2015():960357. PubMed ID: 25821832
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus fumigatus biofilm on primary human sinonasal epithelial culture.
Singhal D; Baker L; Wormald PJ; Tan L
Am J Rhinol Allergy; 2011; 25(4):219-25. PubMed ID: 21819757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
